Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally Y Zhang, SH Kwon, T Yamaguchi, F Cubizolles, S Rousseaux, M Kneissel, ... Molecular and cellular biology 28 (5), 1688-1701, 2008 | 643 | 2008 |
The deacetylase HDAC6 is a novel critical component of stress granules involved in the stress response SH Kwon, Y Zhang, P Matthias Genes & development 21 (24), 3381-3394, 2007 | 451 | 2007 |
HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates C Boyault, Y Zhang, S Fritah, C Caron, B Gilquin, SH Kwon, C Garrido, ... Genes & development 21 (17), 2172-2181, 2007 | 407 | 2007 |
Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes Y Li, D Shin, SH Kwon The FEBS journal 280 (3), 775-793, 2013 | 385 | 2013 |
Apicidin, a histone deacetylase inhibitor, induces apoptosis and Fas/Fas ligand expression in human acute promyelocytic leukemia cells SH Kwon, SH Ahn, YK Kim, GU Bae, JW Yoon, S Hong, HY Lee, YW Lee, ... Journal of Biological Chemistry 277 (3), 2073-2080, 2002 | 283 | 2002 |
The changing faces of HP1: From heterochromatin formation and gene silencing to euchromatic gene expression: HP1 acts as a positive regulator of transcription SH Kwon, JL Workman Bioessays 33 (4), 280-289, 2011 | 189 | 2011 |
The heterochromatin protein 1 (HP1) family: put away a bias toward HP1 SH Kwon, JL Workman Molecules and cells 26 (3), 217-227, 2008 | 169 | 2008 |
MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer JH Noh, YG Chang, MG Kim, KH Jung, JK Kim, HJ Bae, JW Eun, Q Shen, ... Cancer letters 335 (2), 455-462, 2013 | 127 | 2013 |
Heterochromatin protein 1 (HP1) connects the FACT histone chaperone complex to the phosphorylated CTD of RNA polymerase II SH Kwon, L Florens, SK Swanson, MP Washburn, SM Abmayr, ... Genes & development 24 (19), 2133-2145, 2010 | 108 | 2010 |
Advances in histone demethylase KDM4 as cancer therapeutic targets DH Lee, GW Kim, YH Jeon, J Yoo, SW Lee, SH Kwon The FASEB Journal 34 (3), 3461-3484, 2020 | 99 | 2020 |
Advances in epigenetic glioblastoma therapy DH Lee, HW Ryu, HR Won, SH Kwon Oncotarget 8 (11), 18577, 2017 | 97 | 2017 |
Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53 EK Park, JC Lee, JW Park, SY Bang, SA Yi, BK Kim, JH Park, SH Kwon, ... Cell death & disease 6 (11), e1964-e1964, 2015 | 96 | 2015 |
Tripartin, a histone demethylase inhibitor from a bacterium associated with a dung beetle larva SH Kim, SH Kwon, SH Park, JK Lee, HS Bang, SJ Nam, HC Kwon, J Shin, ... Organic letters 15 (8), 1834-1837, 2013 | 95 | 2013 |
HDAC6 deacetylates p53 at lysines 381/382 and differentially coordinates p53-induced apoptosis HW Ryu, DH Shin, DH Lee, J Choi, G Han, KY Lee, SH Kwon Cancer letters 391, 162-171, 2017 | 76 | 2017 |
Influence of toxicologically relevant metals on human epigenetic regulation HW Ryu, DH Lee, HR Won, KH Kim, YJ Seong, SH Kwon Toxicological research 31, 1-9, 2015 | 69 | 2015 |
Protein L-isoaspartyl methyltransferase regulates p53 activity JC Lee, SU Kang, Y Jeon, JW Park, JS You, SW Ha, N Bae, G Lubec, ... Nature communications 3 (1), 927, 2012 | 65 | 2012 |
Broad domains of histone H3 lysine 4 trimethylation in transcriptional regulation and disease S Park, GW Kim, SH Kwon, JS Lee The FEBS journal 287 (14), 2891-2902, 2020 | 61 | 2020 |
A new role for the ginsenoside RG3 in antiaging via mitochondria function in ultraviolet-irradiated human dermal fibroblasts H Lee, Y Hong, Q Tran, H Cho, M Kim, C Kim, SH Kwon, SJ Park, J Park, ... Journal of ginseng research 43 (3), 431-441, 2019 | 51 | 2019 |
Advances in histone demethylase KDM3A as a cancer therapeutic target J Yoo, YH Jeon, HY Cho, SW Lee, GW Kim, DH Lee, SH Kwon Cancers 12 (5), 1098, 2020 | 50 | 2020 |
Glutamine synthetase as a therapeutic target for cancer treatment GW Kim, DH Lee, YH Jeon, J Yoo, SY Kim, SW Lee, HY Cho, SH Kwon International journal of molecular sciences 22 (4), 1701, 2021 | 42 | 2021 |